Ophthotech reported $50.36M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alimera Sciences ALIM:US $ 24.78M 16.51M
Applied Genetic Technologies AGTC:US $ 105.05M 15.52M
Cytrx CYTR:US 8.43M 887.69K
Insmed INSM:US $ 928.33M 518.58M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Novartis NOVN:VX SF 5117M 1316M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M